Skip to main content
Phasix™ ST Mesh Image

Phasix™ ST Mesh Image
Phasix™ ST Mesh

Fully Resorbable Scaffold Featuring Proven Sepra® Technology

Healthcare Professional Downloads:

Request Information Customer Service
1-800-556-6275

Designed to enable functional tissue remodeling for a strong repair

Phasix™ ST Mesh combines two market-leading technologies into one product: monofilament resorbable Phasix™ Mesh and a proven hydrogel barrier based on Sepra® technology. While the monofilament mesh supports functional healing and a strong repair, the hydrogel barrier minimizes tissue attachment to the visceral side of the mesh for intraabdominal placement.1

WHAT IS PHASIX™ ST MESH? 

Phasix™ ST Mesh combines two market-leading technologies into one product: monofilament resorbable Phasix™ Mesh and a proven hydrogel barrier based on Sepra® technology.

phasix vs. sepra

Click Here to learn more about Phasix™ Mesh

THE NEXT PHASE IN HERNIA REPAIR

Repairs. *

The open monofilament mesh structure provides early integration and repair strength.1
 

Remodels. *

Vascular integration and incorporation continues, with abundant mature collagen at 52 weeks. Gradually transfers load to native tissue over time. 1
 

Restores. *

As Phasix™ Mesh is remodeled, it is replaced with functional tissue, ultimately resulting in a strong repair at one year.1

long-term strength

1 Preclinical data on file at C. R. Bard, Inc. Phasix™ ST Mesh shows similar mechanical strength over time to Phasix™ Mesh in a preclinical model. Results may not correlate to clinical performance in humans.
2 Preclinical data on file. Results may not correlate to clinical performance in humans.
3 Deeken CR, Matthews BD. “Characterization of the mechanical strength, resorption properties, and histologic characteristics of a fully absorbable material (Poly-4-hydroxybutyrate—Phasix™ Mesh) in a porcine model of hernia repair.” ISRN Surgery 2013; 1-12.
4 Deeken CR, Abdo MS, Frisella MM, Matthews BD. “Physicomechanical evaluation of absorbable and nonabsorbable barrier composite meshes for laparoscopic ventral hernia repair.” Surgical Endoscopy 25.5 (2010): 1541-552.
5 Estimated from Standard Curve in manuscript (Martin, et al. JSR 2013).

WHY PHASIX™ ST?

Why Phasix

1 Preclinical data on file at C. R. Bard, Inc. Results may not correlate to clinical performance in humans.
2 Nguyen PT, Asarias JR, Pierce LM. “Influence of a new monofilament polyester mesh on inflammation and matrix remodeling.” J Invest Surg 2012; 25: 330
3 Bryan N, Ahswin H, Smart NJ, Bayon Y, Hunt JA. “In vitro activation of human leukocytes in response to contact with synthetic hernia meshes.” Clin Biochem 2012; 45: 672
4 Aydinuraz K, Agalar C, Agalar F, Ceken S, Buruyurek N, Voral T. “In vitro S. epidermidis and S. aureus adherence to composite and lightweight polypropylene grafts.” J Surg Res 2009; 157: e79.
5 Amid PK, Shulman AG, Lichtenstein IL, Hakaha M. “Biomaterials for abdominal wall hernia surgery and principles of their applications.” Langenbecks Archive Chir 1994; 379(3): 168-71.
6 Klinge U, Junge B, Spellerberg B, Piroth C, Klosterhalfen B, Schumpelick V. “Do multifilament alloplastic meshes increase the infection rate? Analysis of the polymeric surface, the bacterial adherence, and the in vivo consequences in a rat model.” J Biomed Mater Res (Appl Biomater) 2002; (63): 765-771.
7 Long-term clinical data not yet available.

MATERIAL STRUCTURE1

Monofilament mesh designs have been deemed more biocompatible and less susceptible to bacterial adherence and colonization.2,3,4,5,6 

phasix SEM

1 Preclinical data on file at C. R. Bard, Inc. Results may not correlate to clinical performance in humans.
2 Nguyen PT, Asarias JR, Pierce LM. “Influence of a new monofilament polyester mesh on inflammation and matrix remodeling.” J Invest Surg 2012; 25: 330
3 Bryan N, Ahswin H, Smart NJ, Bayon Y, Hunt JA. “In vitro activation of human leukocytes in response to contact with synthetic hernia meshes.” Clin Biochem 2012; 45: 672
4 Aydinuraz K, Agalar C, Agalar F, Ceken S, Buruyurek N, Voral T. “In vitro S. epidermidis and S. aureus adherence to composite and lightweight polypropylene grafts.” J Surg Res 2009; 157: e79.
5 Amid PK, Shulman AG, Lichtenstein IL, Hakaha M. “Biomaterials for abdominal wall hernia surgery and principles of their applications.” Langenbecks Archive Chir 1994; 379(3): 168-71.
6 Klinge U, Junge B, Spellerberg B, Piroth C, Klosterhalfen B, Schumpelick V. “Do multifilament alloplastic meshes increase the infection rate? Analysis of the polymeric surface, the bacterial adherence, and the in vivo consequences in a rat model.” J Biomed Mater Res (Appl Biomater) 2002; (63): 765-771.
7 Long-term clinical data not yet available.

TISSUE INCORPORATION

At 12 weeks, Phasix™ ST Mesh is well incorporated with new vascularized tissue and minimal inflammatory response. A new peritoneal layer has been laid down in place of the ST barrier. By 48 weeks, Phasix™ ST Mesh continues to be remodeled and is replaced with mature functional tissue.1

12 week image

1 Preclinical data on file; results may not correlate to clinical performance in humans.

BioSurgery Surgical Education

The following pages will introduce you to Bard’s BioSurgical Education modalities and faculty. We are committed to advanced professional education – helping you choose the right products and procedures to provide the right outcomes for your patients.

Soft Tissue Repair Education

Bard® Surgical Education Programs are designed to provide you with focused and flexible modalities providing in-depth education on products and techniques intended to help you optimize patient care.

Selecting a partner for surgical products can be a difficult decision. There is a lot at stake for many people in your organization, including Operating Room Managers, Surgeons, Materials Management and of course your patients. For this reason Bard Davol provides information on our products and product portfolios that help you simplify the selection process and puts pertinent, important information at your finger tips.

Our commitment to your success extends beyond the OR. We also offer access to our Customer Service, Medical Services and Support, Reimbursement Hotline and our world-class Surgeon Education groups. These are resources Bard Davol invests in for your success, staffed by experts who are passionate about offering you the best service and experience possible.

For more information, visit: http://www.davol.com/value-analysis/

Specifications

Product Item IDProduct Item NamePackaging (SKU)Dimensions
1200008Phasix™ ST Mesh1/cs.Round 3" (8 cm)
1200011Phasix™ ST Mesh1/cs.Round 4.5" (11 cm)
1200015Phasix™ ST Mesh1/cs.Round 6" (15 cm)
1200710Phasix™ ST Mesh1/cs.Rectangle 3" x 4" (7 cm x 10 cm)
1201010Phasix™ ST Mesh1/cs.Square 4" x 4" (10 cm x 10 cm)
1201015Phasix™ ST Mesh1/cs.Rectangle 4" x 6" (10 cm x 15 cm)
1201020Phasix™ ST Mesh1/cs.Rectangle 4" x 8" (10 cm x 20 cm)
1201325Phasix™ ST Mesh1/cs.Rectangle 5" x 10" (13 cm x 25 cm)
1201520Phasix™ ST Mesh1/cs.Rectangle 6" x 8" (15 cm x 20 cm)
1202025Phasix™ ST Mesh1/cs.Rectangle 8" x 10" (20 cm x 25 cm)
1202530Phasix™ ST Mesh1/cs.Rectangle 10" x 12" (25 cm x 30 cm)
1203035Phasix™ ST Mesh1/cs.Rectangle 12" x 14" (30 cm x 35 cm)

Related Products

Phasix™ Mesh

Phasix™ Mesh

> View Product
XenMatrix™ AB Surgical Graft

XenMatrix™ AB Surgical Graft

> View Product

1 Preclinical data on file at C. R. Bard, Inc. Results may not correlate to clinical performance in humans.
2 Nguyen PT, Asarias JR, Pierce LM. “Influence of a new monofilament polyester mesh on inflammation and matrix remodeling.” J Invest Surg 2012; 25: 330
3 Bryan N, Ahswin H, Smart NJ, Bayon Y, Hunt JA. “In vitro activation of human leukocytes in response to contact with synthetic hernia meshes.” Clin Biochem 2012; 45: 672
4 Aydinuraz K, Agalar C, Agalar F, Ceken S, Buruyurek N, Voral T. “In vitro S. epidermidis and S. aureus adherence to composite and lightweight polypropylene grafts.” J Surg Res 2009; 157: e79.
5 Amid PK, Shulman AG, Lichtenstein IL, Hakaha M. “Biomaterials for abdominal wall hernia surgery and principles of their applications.” Langenbecks Archive Chir 1994; 379(3): 168-71.
6 Klinge U, Junge B, Spellerberg B, Piroth C, Klosterhalfen B, Schumpelick V. “Do multifilament alloplastic meshes increase the infection rate? Analysis of the polymeric surface, the bacterial adherence, and the in vivo consequences in a rat model.” J Biomed Mater Res (Appl Biomater) 2002; (63): 765-771.
7 Long-term clinical data not yet available.

5